Log in or Sign up for Free to view tailored content for your specialty!
Immunodermatology News
Cutaneous granulomas associated with vaccine-derived and wild type rubella virus
Clinicians should consider rubella virus as a potential contributor to granulomatous skin disease in both immunodeficient and immunocompetent patients, according to a study.
Nielsen enters agreement with Maruho for marketing rights to verruca vulgaris treatment
Nielsen BioSciences Inc. and Maruho Co. Ltd. have entered into a licensing agreement that grants Maruho an exclusive license to market CANDIN in Japan for the treatment of verruca vulgaris, according to a press release.
Log in or Sign up for Free to view tailored content for your specialty!
No significant increase in autoimmune, autoinflammatory risks with mRNA COVID-19 vaccine
The mRNA-based COVID-19 vaccine does not significantly increase the risk of autoimmune or autoinflammatory diseases, according to data published in the Journal of the American Academy of Dermatology.
‘Treatment is not one size fits all’: Sarcoidosis management must be individualized
DESTIN, Fla. — Complicated disease pathogenesis and a lack of FDA-approved therapies makes sarcoidosis a significant clinical challenge, according to a presenter at the 2023 Congress of Clinical Rheumatology-East.
JAK inhibitors could be promising in sarcoidosis treatment
NEW ORLEANS — Janus kinase inhibitors could be promising in the treatment of cutaneous sarcoidosis, which currently has no FDA-approved treatment options, according to a speaker here.
Pain assessment in HS trials may require information on pain recall, intensity
Details on pain recall may be necessary to supplement the numerical rating and VAS for pain assessment in clinical trials of hidradenitis suppurativa, according to a study.
JAKs could be future of pediatric alopecia treatment
WAILEA, Hawaii — Janus kinase inhibitors could be the future of alopecia areata treatment in children if research proves them to be safer than current warnings suggest, according to a presenter at the Maui Derm meeting.
Cutaneous involvement ‘frequent’ in patients with catastrophic antiphospholipid syndrome
About half of the patients with catastrophic antiphospholipid syndrome have cutaneous involvement, which can help predict outcomes in this condition, according to a study.
Rituximab may prevent long-term comorbidities in treatment of pemphigus
Rituximab is associated with higher protection against long-term cardiovascular and metabolic diseases, but similar in survival rate, compared with other adjuvant agents in the treatment of pemphigus, according to a study.
Male providers more likely to prescribe biologic immune modifiers, oral small molecules
Men, along with clinicians with more than 4 years’ experience, were more likely than women and less experienced providers to prescribe oral small molecule medications and biologic immune response modifiers, according to a study.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read